Power Play: Quach on NACI's J&J advice Dr. Caroline Quach discusses NACI's advice for the Johnson & Johnson vaccine, which seems to contradict what's coming from Health Canada.

Moderna is down 34.5% since the beginning of the year, and at $27.52 per share, it is trading 42.1% below its 52-week high of ...

When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...

The "warp speed" assistance of the US government to help pharmaceutical companies create COVID-19 vaccines has been an amazing moonshot for science and civilization. It turned a small biotechnology ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

The two COVID-19 vaccines approved in Canada were created by using ground-breaking genetic technology that for years held huge promise, but always ran into roadblocks — until now. It’s called ...

Scientists dropped everything to focus on a COVID-19 vaccine. Its success will change the future of medicine (Frauke Bönsch) In the early days of the COVID-19 pandemic, when the novel coronavirus was ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...